Blar i forfatter "Rossi, Mariateresa"

Viser treff 1-2 av 2

    • Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study 

      Calzavara-Pinton, Piergiacomo; Čelakovská, Jarmila; Lapeere, Hilde; Holzer, Gregor; Al-Ahmad, Mona; Chu, Chia-Yu; Ferrucci, Silvia M.; Kataoka, Yoko; Rossi, Mariateresa; Fomina, Daria S.; Chung, Wen-Hung; Tzellos, Thrasyvoulos; Fougerousse, Anne-Claire; Wu, Jiangming; Ardeleanu, Marius; Ozturk, Zafer E. (Journal article; Tidsskriftartikkel; Peer reviewed, 2023-10-06)
      Introduction - Insights into real-world treatment of atopic dermatitis (AD) are relevant to clinical decision making. The aim of this analysis was to characterize patients who receive dupilumab for AD in a real-world setting.<p> <p>Methods - The GLOBOSTAD registry is an ongoing, longitudinal, prospective, observational study of patients with AD who receive dupilumab according to country-specific ...

    • One-Year Insights into the GLOBOSTAD Multinational Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis 

      Calzavara-Pinton, Piergiacomo; Chu, Chia-Yu; Lapeere, Hilde; Rossi, Mariateresa; Ferrucci, Silvia M.; Chung, Wen-Hung; Fougerousse, Anne-Claire; Fomina, Daria S.; Holzer, Gregor; Čelakovská, Jarmila; Al-Ahmad, Mona; Tzellos, Thrasyvoulos; Wu, Jiangming; Ardeleanu, Marius; Bosman, Kwinten (Journal article; Tidsskriftartikkel; Peer reviewed, 2024-12-02)
      Introduction Currently, limited data are available on long-term use of dupilumab to treat atopic dermatitis (AD) in a multinational real-world setting. The aim of this analysis was to report the interim 1-year data for patients with AD enrolled in the GLOBOSTAD registry, including treatment patterns, dupilumab effectiveness and safety, and healthcare burden.<p> <p>Methods GLOBOSTAD is an ongoing, ...